请拖入内容到容器
请拖入内容到容器

Category one

Category two

Category three

请拖入内容到容器
Copycats wanted: Pfizer, AZ and more under threat as China solicits generics
Abstract:
The U.S. FDA compiles a list of off-patent drugs without an approved generic to encourage the development of copycats. Now, the Chinese authorities are rolling out a similar initiative, only with some extra incentives.
2019 CHPI Exhibition in Shanghai
China smacks 48 officials, including ex-FDA official, in Changsheng vaccine scandal
Abstract:
China’s anticorruption authorities have punished 48 officials found responsible for the Changchun Changsheng Life Sciences vaccine scandal that provoked public outrage last summer.
EU expands look at Zhejiang Huahai as impurities show up in other 'sartans'
Abstract:
A global recall may get expanded beyond valsartan as regulators continue to find potentially cancer-causing impurities in other “sartan” products. European regulators say they have found the same impurity discovered in valsartan in both losartan made by Hetero Labs and now irbesartan by Aurobindo Pharma.
请拖入内容到容器

首页联系方式

Shandong Sihuan Pharmaceutical Co.,Ltd.
Add :Nanyuan Road, Economic Development Zone,Pingyuan County, Dezhou City,Shandong Province, China. 
 
Tel:+86-531-89702887 +86-531-88993983 +86-531-88993893
Fax:+86-531-89702886 

Webpage Copyright:Shandong Sihuan Pharmaceutical Co.,Ltd.  |  ICP Register No.: 鲁ICP备17046678号-1 | Powered by www.300.cn JINAN

请拖入内容到容器
Search